US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist
  • 1.050
  • -0.010-0.94%
Close Aug 2 16:00 ET
  • 1.050
  • 0.0000.00%
Post 20:01 ET
26.43MMarket Cap-700P/E (TTM)

Gain Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Aug 2, 2024

Based on 2 analysts giving stock ratings to Gain Therapeutics in the past 3 months

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Aug 2, 2024

The average Gain Therapeutics stock price target is 8.00 with a max estimate of 8.00 and a min estimate of 8.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Aug 2, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Aug 2, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg